Emerging therapies of hepatitis B and C

J Gastroenterol Hepatol. 2002 Dec:17 Suppl:S471-81. doi: 10.1046/j.1440-1746.17.s4.13.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Adjuvants, Immunologic / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • Carcinoma, Hepatocellular / etiology*
  • Carcinoma, Hepatocellular / physiopathology
  • Carcinoma, Hepatocellular / prevention & control*
  • Hepacivirus / drug effects
  • Hepacivirus / genetics
  • Hepacivirus / physiology
  • Hepatitis B virus / drug effects
  • Hepatitis B virus / genetics
  • Hepatitis B virus / physiology
  • Hepatitis B, Chronic / complications*
  • Hepatitis B, Chronic / drug therapy*
  • Hepatitis B, Chronic / physiopathology
  • Hepatitis C, Chronic / complications*
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / physiopathology
  • Humans
  • Liver Cirrhosis / etiology*
  • Liver Cirrhosis / physiopathology
  • Liver Cirrhosis / prevention & control*
  • Liver Neoplasms / etiology*
  • Liver Neoplasms / physiopathology
  • Liver Neoplasms / prevention & control*
  • Reverse Transcriptase Inhibitors / therapeutic use*

Substances

  • Adjuvants, Immunologic
  • Antiviral Agents
  • Reverse Transcriptase Inhibitors